norfluoxetine and Disease Models, Animal

norfluoxetine has been researched along with Disease Models, Animal in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chung, YC; Jin, BK; Kim, KI1
Gross, S; Oh, JE; Toth, M; Zupan, B1
Harasztosi, C; Kecskeméti, V; Nánási, PP; Pál, B; Riba, P; Rusznák, Z; Szûcs, G; Wagner, R1

Other Studies

3 other study(ies) available for norfluoxetine and Disease Models, Animal

ArticleYear
Norfluoxetine Prevents Degeneration of Dopamine Neurons by Inhibiting Microglia-Derived Oxidative Stress in an MPTP Mouse Model of Parkinson's Disease.
    Mediators of inflammation, 2018, Volume: 2018

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Disease Models, Animal; Dopaminergic Neurons; Fluoxetine; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Microglia; Oxidative Stress; Parkinson Disease; Rats; Rats, Sprague-Dawley

2018
Paradoxical anxiogenic response of juvenile mice to fluoxetine.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2009, Volume: 34, Issue:10

    Topics: Age Factors; Analysis of Variance; Animals; Animals, Newborn; Anxiety; Behavior, Animal; Cell Proliferation; Dentate Gyrus; Disease Models, Animal; Dose-Response Relationship, Drug; Drinking Behavior; Drug Administration Schedule; Exploratory Behavior; Fluoxetine; Infusion Pumps, Implantable; Male; Maze Learning; Mice; Mice, Inbred Strains; Reaction Time; Selective Serotonin Reuptake Inhibitors; Swimming

2009
Norfluoxetine and fluoxetine have similar anticonvulsant and Ca2+ channel blocking potencies.
    Brain research bulletin, 2005, Sep-30, Volume: 67, Issue:1-2

    Topics: Animals; Anticonvulsants; Barium; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Signaling; Cells, Cultured; Clonazepam; Cochlear Nucleus; Disease Models, Animal; Dose-Response Relationship, Drug; Epilepsy; Fluoxetine; Male; Membrane Potentials; Mice; Neurons, Afferent; Patch-Clamp Techniques; Phenytoin; Selective Serotonin Reuptake Inhibitors

2005